Companies sponsors |
Novo Nordisk (insulin icodec) |
Others |
Department of Health and Social Care |
|
NHS England |
Patient carer groups |
Black Health Agency for Equality |
|
Diabetes Research and Wellness Foundation |
|
Diabetes UK |
|
Haemochromatosis UK |
|
InDependent Diabetes Trust |
|
Network of Sikh Organisations |
|
South Asian Health Foundation |
|
Specialised Healthcare Alliance |
Professional groups |
Association for the Study of Obesity |
|
Association of British Clinical Diabetologists |
|
British & Irish Hypertension Society |
|
British Association for Nursing in Cardiovascular Care |
|
British Geriatrics Society |
|
British Heart Foundation |
|
Primary Care Diabetes Society |
|
Royal College of General Practitioners |
|
Royal College of Nursing |
|
Royal College of Pathologists |
|
Royal College of Physicians |
|
Royal Pharmaceutical Society |
|
Royal Society of Medicine |
|
Society for Endocrinology |
|
TREND Diabetes |
|
UK Clinical Pharmacy Association |
Associated public health groups |
Public Health Wales |
|
UK Health Security Agency |
Comparator companies |
A. Menarini Farmaceutica Internazionale (canagliflozin, metformin) |
|
AstraZeneca (exenatide, dapagliflozin, metformin, saxagliptin) |
|
Aurobindo Pharma (gliclazide, metformin, sitagliptin, vildagliptin) |
|
Bioproject (glibenclamide) |
|
Boehringer Ingelheim (empagliflozin, linagliptin, metformin) |
|
Bristol laboratories (gliclazide) |
|
Brown and Burk UK (gliclazide, glimepiride, metformin, pioglitazone) |
|
Celix Pharma (metformin, sitagliptin) |
|
Colonis Pharma (metformin) |
|
Dr Reddy’s Laboratories (metformin, sitagliptin) |
|
Eli Lilly (dulaglutide, insulin, tirzepatide) |
|
Flamingo Pharma (gliclazide) |
|
Genus Pharmaceuticals (metformin, sitagliptin) |
|
Glenmark Pharmaceuticals (metformin, sitagliptin) |
|
Ipca Laboratories (metformin) |
|
Krka UK (gliclazide, sitagliptin) |
|
Lupin Healthcare (gliclazide) |
|
Morningside Healthcare (metformin) |
|
MSD (ertugliflozin, metformin, sitagliptin) |
|
Mylan (gliclazide, insulin, pioglitazone, sitagliptin) |
|
Neon Healthcare (metformin, pioglitazone) |
|
Novartis (metformin, vildagliptin) |
|
Novo Nordisk (insulin, liraglutide, semaglutide) |
|
Pfizer (glipizide) |
|
Pinewood Healthcare (metformin) |
|
Rosemont Pharmaceuticals (metformin) |
|
Sandoz (metformin, pioglitazone) |
|
Sanofi (insulin, lixisenatide) |
|
Servier Laboratories (gliclazide) |
|
Sigma Pharmaceuticals (metformin) |
|
Sovereign Medical (tolbutamide) |
|
Strides Pharma (metformin) |
|
Sun Pharmaceuticals (sitagliptin) |
|
Takeda (alogliptin, metformin) |
|
Thame Laboratories (metformin, sitagliptin) |
|
Tillomed Laboratories (metformin) |
|
Wockhardt (metformin) |
|
Zentiva (gliclazide, metformin, sitagliptin) |
General commentators |
All Wales Therapeutics and Toxicology Centre |
|
Allied Health Professionals Federation |
|
Board of Community Health Councils in Wales |
|
British National Formulary |
|
Care Quality Commission |
|
Department of Health - Northern Ireland |
|
Diabetes UK Cymru |
|
Healthcare Improvement Scotland |
|
Medicines and Healthcare products Regulatory Agency |
|
National Association of Primary Care |
|
National Pharmacy Association |
|
NHS Alliance |
|
NHS Confederation |
|
Scottish Medicines Consortium |
|
Welsh Government |
|
Welsh Health Specialised Services Committee |
Relevant research groups |
Cochrane Metabolic & Endocrine Disorders Group |
|
Genomics England |
|
MRC Clinical Trials Unit |
|
National Institute for Health Research |
|
The Society for Research in Rehabilitation |
|
Wellcome Trust |